Who
Jerome D. Jabbour
Director
Company insider
Files Form 4 as: Director, Indaptus Therapeutics; President and CEO, Matinas Biopharma Holdings.
In numbers
- Trades disclosed
- 20
- Buys
- 3
- Sells
- 0
- Bought
- $26K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 22 Mar 2018
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 30 Apr 2025filed 2 May 2025 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,100 at $0.00 | filing |
| 15 Dec 2023filed 15 Dec 2023 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500,000 at $0.00 | filing |
| 20 Dec 2022filed 22 Dec 2022 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,988,300 at $0.00 | filing |
| 14 Dec 2021filed 15 Dec 2021 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,658,100 at $0.00 | filing |
| 19 Jun 2021filed 24 Jun 2021 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code C | —15 at $0.00 | filing |
| 19 Jun 2021filed 24 Jun 2021 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code J | —6,000 at $0.00 | filing |
| 19 Jun 2021filed 24 Jun 2021 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code C | —30,000 at $0.00 | filing |
| 1 Jan 2021filed 4 Jan 2021 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,600,000 at $0.00 | filing |
| 23 Jun 2020filed 24 Jun 2020 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code J | —4,500 at $0.00 | filing |
| 17 Jun 2020filed 19 Jun 2020 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 17 Mar 2020filed 18 Mar 2020 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Bought | $6,50010,000 at $0.65 | filing |
| 1 Jan 2020filed 3 Jan 2020 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 19 Aug 2019filed 21 Aug 2019 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Bought | $9,96214,650 at $0.68 | filing |
| 21 Jun 2019filed 3 Jan 2020 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code J | —3,000 at $0.00 | filing |
| 12 Jun 2019filed 13 Jun 2019 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Bought | $9,99012,487 at $0.80 | filing |
| 11 Feb 2019filed 13 Feb 2019 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 21 Jun 2018filed 22 Jun 2018 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code P | $15K15 at $1,000.00 | filing |
| 22 Mar 2018filed 23 Mar 2018 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
News
Matinas Biopharma Holdings, Inc. (NYSEAMERICAN:MTNB) Shares Shorted: Short Interest Down 87.3% in SeptemberMTNB · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Jerome D. Jabbour; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.